NextCure, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
NXTC on Nasdaq
Industry
Pharmaceutical Preparations
Location
9000 Virginia Manor Road, Suite 200, Beltsville, Maryland

There are no Buy or Sell transactions made by insiders since 7/8/2023

NextCure, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kabakoff David S Director Jun 20, 2024
Ellen Feigal Director Jun 20, 2024
Michael Richman President & CEO, Director Mar 29, 2024
Stephen W. Webster Director Jun 20, 2024
Stella Xu Director Jun 24, 2021
Chau Q. Khuong Director Jun 22, 2023
John G. Houston Director Jun 20, 2024
Sourav Kundu Sr VP, Dev. & Mfg. Mar 29, 2024
Han Myint Chief Medical Officer Mar 29, 2024
Linda Liu SVP, Research Jan 31, 2022
Kevin G. Shaw Sr VP, General Counsel Mar 29, 2024
Anne Borgman Director Jun 20, 2024
Elaine V. Jones Director Jun 20, 2024
Steven P. Cobourn Chief Financial Officer Mar 29, 2024
Timothy Mayer Chief Operating Officer Mar 29, 2024
Sol Langermann Chief Scientific Officer Mar 29, 2024
Garry A. Nicholson Director Jun 22, 2023

Recent Insider Transactions by Companies or Individuals for NextCure, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership